Browsing: Granules India

8 months ago

8 months ago Granules India receives FDA approval for Lisdexamfetamine Dimesylate capsules for treatment of ADHD

8 months ago Granules India Voluntarily Halts Production at Gagillapur Plant Following US FDA Observations

9 months ago

9 months ago Granules India Ltd: Block Trade Indicates Institutional Interest

9 months ago Granules India Receives FDA Approval for ADHD Drug Amidst US Shortages

10 months ago

10 months ago Granules India Responds to US FDA Observations

10 months ago Granules India’s Net-Zero Commitment Validated by SBTi

10 months ago Granules India’s Unit V Facility Receives Positive US FDA Inspection

11 months ago

11 months ago Granules India Secures US FDA Approval for Bupropion Hydrochloride Extended-Release Tablets